Using NetRank, we identified seven genes (STAT3, FOS, JUN, SP1, CDX2, CEBPA, and BRCA1) as most relevant for predicting survival in patients with pancreatic ductal adenocarcinoma. The gene discussed is FOS; the disease is pancreatic ductal adenocarcinoma.